Formulation and evaluation of carrier-based dry powders containing budesonide and arformoterol for inhalation therapy
Authors:
- 20 October 2024
- journal article
- research article
- Published by Taylor & Francis in Pharmaceutical Development and Technology
- Vol. 29 (9) , 966-975
Abstract
Asthma and Chronic Obstructive Pulmonary Disease (COPD) are major global health concerns, with inhalation therapy being a primary treatment method. Dry powder inhalers (DPIs) often face challenges related to particle aggregation, which can diminish drug delivery efficiency. This study investigates particle aggregation and aims to optimize the cohesion-adhesion balance to improve inhalation efficiency. Advanced techniques like atomic force microscopy and Raman imaging were used to analyze particle interactions, focusing on lactose ratios, particle morphology, and drug-drug interactions. The therapeutic efficacy of optimized formulations containing budesonide (BUD) and Arformoterol (AFT) was assessed using an asthma model, showing significant improvements in sRAW, neutrophil count, and tidal volume compared to the positive control, with p-values below 0.01. AFT exhibited comparable efficacy to Formoterol at half the dose. Additionally, pharmacokinetic studies demonstrated similar in vivo behavior between the drugs, confirming the therapeutic advantage of AFT, with p-values for AUC0-t and Cmax of .646 and .153, respectively. The fine particle fractions for AFT and BUD were 39.4% and 50.6%, respectively, indicating improved drug delivery efficiency and potential for better clinical outcomes in asthma and COPD patients.Keywords
Funding Information
- National Research Foundation of Korea (NRF-2021R1A2C4002746, 2017R1A5A2015541)
- Regional Innovation Strategy (2021RIS-001)
- Korea Health Industry Development Institute
- Ministry of Health and Welfare, Republic of Korea (HI14C1069)
This publication has 26 references indexed in Scilit:
- Exploring the impact of extrinsic lactose fines, a USP modified sampling device and modified centrifuge tube on the delivered dose uniformity and drug detachment performance of a fluticasone propionate dry powder inhalerJournal of Drug Delivery Science and Technology, 2020
- Direct Measurement of the Cohesive Law of Adhesives Using a Rigid Double Cantilever Beam TechniqueExperimental Mechanics, 2013
- Dry powder inhalers: Mechanistic evaluation of lactose formulations containing salbutamol sulphateInternational Journal of Pharmaceutics, 2012
- The Influence of Drug Morphology on Aerosolisation Efficiency of Dry Powder Inhaler FormulationsJournal of Pharmaceutical Sciences, 2008
- An Investigation into the Dispersion Mechanisms of Ternary Dry Powder Inhaler Formulations by the Quantification of Interparticulate ForcesPharmaceutical Research, 2007
- The use of colloid probe microscopy to predict aerosolization performance in dry powder inhalers: AFM and in vitro correlationJournal of Pharmaceutical Sciences, 2006
- The Influence of Fine Excipient Particles on the Performance of Carrier-Based Dry Powder Inhalation FormulationsPharmaceutical Research, 2006
- The inhalers of the future? A review of dry powder devices on the market todayPulmonary Pharmacology & Therapeutics, 2003
- Polymorphic Discrimination Using Atomic Force Microscopy: Distinguishing between Two Polymorphs of the Drug CimetidineLangmuir, 1999
- Direct Measurement of Particle−Bubble Interactions in Aqueous Electrolyte: Dependence on SurfactantLangmuir, 1998